Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer.
about
HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cellsThe role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progressionAlternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedProteomic analysis of differential protein expression in early process of pancreatic regeneration in pancreatectomized ratsA proteomic comparison of immature and mature mouse gonadotrophs reveals novel differentially expressed nuclear proteins that regulate gonadotropin gene transcription and RNA splicingIdentification of selectively expressed genes and antigens in CTCL.BRCA1 modulates the expression of hnRNPA2B1 and KHSRP.Altered profiles of nuclear matrix proteins during the differentiation of human gastric mucous adenocarcinoma MGc80-3 cells.Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor.Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinomaExpression proteomics of UPF1 knockdown in HeLa cells reveals autoregulation of hnRNP A2/B1 mediated by alternative splicing resulting in nonsense-mediated mRNA decay.The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer.Intact protein profiling in breast cancer biomarker discovery: protein identification issue and the solutions based on 3D protein separation, bottom-up and top-down mass spectrometry.Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets.Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA.Splicing in oncogenesis and tumor suppression.Deregulation of splicing factors and breast cancer development.Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma developmentIdentification of the novel interacting partners of the mammalian target of rapamycin complex 1 in human CCRF-CEM and HEK293 cells.Natural compounds for pediatric cancer treatment.An RNA matchmaker protein regulates the activity of the long noncoding RNA HOTAIRNF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.Splicing-factor alterations in cancers.Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer.Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia.Integrated proteomic platforms for the comparative characterization of medulloblastoma and pilocytic astrocytoma pediatric brain tumors: a preliminary study.HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer.Altered expression patterns of heterogeneous nuclear ribonucleoproteins A2 and B1 in the adrenal cortex.Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.Downregulation of hnRNP A2/B1 expression in tumor cells under prolonged hypoxia.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the self-renewal and pluripotency of human embryonic stem cells via the control of the G1/S transition.A proteomic approach to study parathyroid glands
P2860
Q21559659-8FAD32E6-AE5E-4B7F-81A4-6901E92147B7Q28083838-51A4F3C7-B75D-45F6-9132-3360E070A25CQ28297381-56EE9D6B-6C25-4885-BD9E-BAE4FAADCDFFQ28580712-4409050E-FAC8-4A26-B482-64F0421C5027Q28587333-619E8B9E-4FBB-42FE-9404-E10A4F6A4CB1Q30835465-8F23CC47-3975-4C80-9E35-5ACC4E7EA4B4Q30992379-12741B64-2789-4119-B0FA-F97977459840Q33221541-B86AC17F-A35E-4E45-9198-4351E1288AE3Q33223554-5CED41C3-0B0F-4999-87D9-DE500D510C11Q33625984-FEB14881-461F-41D6-B66A-A97A06EC65D8Q33718674-D1AC040A-67A0-4352-B82D-327DADCD5D0EQ34143021-F1EA7DFC-0D51-4827-A300-F5835525C851Q34543305-5E20260A-B31C-494A-AAE1-CD99CD79A377Q34734385-097B2BB1-0FA1-4ED6-B59C-78E77CF14CA1Q35362977-0984885A-E36B-4260-B21E-EC339D6C6DE8Q38018123-5F3B3831-C8D8-4FE3-B8D5-583E7E92D8CBQ38463397-FF39B4FE-BD3C-49E5-9534-50EF0B8AFDDCQ38487106-90A40A6B-8397-4DDA-99CF-1DAC7BB5E6FEQ38612792-6F300377-4329-4A86-B5DF-CCF90B668A78Q38663897-34B42D78-7779-4809-BBF2-2EC632C2BCA9Q38773163-1981666B-75A8-40B0-B214-BEF201CEB322Q38865962-57EC944D-4863-4104-8D15-7A92C02E5FB4Q38929098-BB41476B-5DF9-48BA-8E9E-5569450FB6D5Q38931288-F6E14276-84DA-4817-8924-9A4EF6D3D9F7Q38965986-693D038D-5E68-4B4F-8347-6888E4EEC55DQ39014494-B26908EB-27F7-4CDF-8B3D-EB8D0151C772Q39763266-05B4A356-57C6-4A85-8AD3-7DF3F4DABD04Q40439712-70678D53-1FAD-4D66-BA85-45B7D4988243Q47784889-694A39A8-49E2-420B-A736-FF9296ED5236Q51693184-AC085122-FF2D-4368-AB5C-B068D509E289Q52564290-50723781-F714-4009-B1E8-83E273AB642AQ54444052-DD6E20F9-17C3-487D-B6A4-A840B6285902Q59033585-B25488A6-6189-414D-9728-D339C0441A1F
P2860
Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Differential expression of the ...... and neoplastic breast cancer.
@ast
Differential expression of the ...... and neoplastic breast cancer.
@en
Differential expression of the ...... and neoplastic breast cancer.
@nl
type
label
Differential expression of the ...... and neoplastic breast cancer.
@ast
Differential expression of the ...... and neoplastic breast cancer.
@en
Differential expression of the ...... and neoplastic breast cancer.
@nl
prefLabel
Differential expression of the ...... and neoplastic breast cancer.
@ast
Differential expression of the ...... and neoplastic breast cancer.
@en
Differential expression of the ...... and neoplastic breast cancer.
@nl
P2093
P2860
P356
P1476
Differential expression of the ...... t and neoplastic breast cancer
@en
P2093
A M Treston
D C Allred
J L Mulshine
P2860
P2888
P304
P356
10.1023/A:1010631915831
P407
P50
P577
2001-04-01T00:00:00Z
P6179
1034381861